These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. Alkhouri N, Carter-Kent C, Lopez R, Rosenberg WM, Pinzani M, Bedogni G, Feldstein AE, Nobili V. Clin Gastroenterol Hepatol; 2011 Feb; 9(2):150-5. PubMed ID: 20888433 [Abstract] [Full Text] [Related]
3. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y, Yonemitsu K, Higurashi T, Takahashi H, Kobayashi N, Kirikoshi H, Abe Y, Inamori M, Kubota K, Saito S, Tamano M, Hiraishi H, Maeyama S, Yamaguchi N, Togo S, Nakajima A. Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083 [Abstract] [Full Text] [Related]
4. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M. J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598 [Abstract] [Full Text] [Related]
8. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, Fruhwirth R, Marcellini M, Pinzani M. Hepatology; 2008 Aug; 48(2):442-8. PubMed ID: 18563842 [Abstract] [Full Text] [Related]
9. Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression. Ekstedt M, Franzén LE, Mathiesen UL, Kechagias S. Scand J Gastroenterol; 2012 Jan; 47(1):108-15. PubMed ID: 22126450 [Abstract] [Full Text] [Related]
11. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. Myers RP, Pomier-Layrargues G, Kirsch R, Pollett A, Beaton M, Levstik M, Duarte-Rojo A, Wong D, Crotty P, Elkashab M. J Hepatol; 2012 Mar; 56(3):564-70. PubMed ID: 22027584 [Abstract] [Full Text] [Related]
12. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y, Ono M, Eguchi Y, Inoue T, Yamanaka T, Wada K, Saito S, Nakajima A. Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985 [Abstract] [Full Text] [Related]
13. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients. Beckebaum S, Iacob S, Klein CG, Dechêne A, Varghese J, Baba HA, Sotiropoulos GC, Paul A, Gerken G, Cicinnati VR. Transplantation; 2010 Apr 27; 89(8):983-93. PubMed ID: 20335832 [Abstract] [Full Text] [Related]
14. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Verma S, Jensen D, Hart J, Mohanty SR. Liver Int; 2013 Oct 27; 33(9):1398-405. PubMed ID: 23763360 [Abstract] [Full Text] [Related]
15. A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. Aykut UE, Akyuz U, Yesil A, Eren F, Gerin F, Ergelen R, Celikel CA, Yilmaz Y. Scand J Gastroenterol; 2014 Nov 27; 49(11):1343-8. PubMed ID: 25259621 [Abstract] [Full Text] [Related]
16. Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience. Lee CK, Perez-Atayde AR, Mitchell PD, Raza R, Afdhal NH, Jonas MM. J Pediatr; 2013 Oct 27; 163(4):1058-64.e2. PubMed ID: 23759423 [Abstract] [Full Text] [Related]
17. Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease. Nobili V, Alkhouri N, Bartuli A, Manco M, Lopez R, Alisi A, Feldstein AE. Pediatr Res; 2010 Jun 27; 67(6):665-70. PubMed ID: 20496475 [Abstract] [Full Text] [Related]
18. Stepwise combination of simple noninvasive fibrosis scoring systems increases diagnostic accuracy in nonalcoholic fatty liver disease. Demir M, Lang S, Nierhoff D, Drebber U, Hardt A, Wedemeyer I, Schulte S, Quasdorff M, Goeser T, Töx U, Steffen HM. J Clin Gastroenterol; 2013 Sep 27; 47(8):719-26. PubMed ID: 23442837 [Abstract] [Full Text] [Related]
19. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Gut; 2010 Sep 27; 59(9):1265-9. PubMed ID: 20801772 [Abstract] [Full Text] [Related]
20. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease. Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I, Kaczmarski M. Acta Biochim Pol; 2011 Sep 27; 58(4):563-6. PubMed ID: 22140659 [Abstract] [Full Text] [Related] Page: [Next] [New Search]